1. Direct antiglobulin test in the differential diagnosis of ABO hemolytic disease of the newborn: an important tool with high negative predictive value
- Author
-
Samira Ali Abbas, Carla Luana Dinardo, Cárlei Heckert Godinho, Karen Ziza, Bruno Cruz, Juliana Oliveira Martins, Elyse Moritz, Dante M. Langui, and José O. Bordin
- Subjects
ABO hemolytic disease ,Newborn ,Direct antiglobulin test ,Diseases of the blood and blood-forming organs ,RC633-647.5 - Abstract
Background: Hemolysis due to ABO incompatibility is an important differential diagnosis in newborns presenting with jaundice. Clinical studies evaluating ABO hemolytic disease of fetus and newborn (ABO-HDFN) question the diagnostic value of the direct antiglobulin test (DAT) in this situation. Goals: To determine the clinical and laboratorial findings associated with the occurrence of ABO-HDFN and to evaluate the accuracy of DAT as a diagnostic tool. Methods: This was a nested case control study with a cohort of 4122 newborns. Clinical and immunohematological data were retrieved from medical files including clinical and laboratorial factors associated with ABO-HDFN. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of positive DAT were calculated. Results: Among the 4122 newborns, 44 had the diagnosis of ABO-HDFN. Positive DAT, group O mother and group A newborn were significantly associated with the occurrence of neonatal jaundice and this association persisted in a multivariable model (p-value
- Published
- 2024
- Full Text
- View/download PDF